XILIO THERAPEUTICS INC

Ticker: XLO CUSIP: 98422T100 Class: COM

BRIDGEWAY CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001107261)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 56,081 Value ($000) $36 Avg Close $0.75 Range $0.63 - $0.90
Q3 2025
Shares 56,081 Value ($000) $47 Avg Close $0.72 Range $0.61 - $0.91
Q2 2025
Shares 56,081 Value ($000) $38 Avg Close $0.75 Range $0.62 - $1.18
Q1 2025
Shares 71,081 Value ($000) $51 Avg Close $0.90 Range $0.63 - $1.70
Q4 2024
Shares 71,081 Value ($000) $68 Avg Close $0.98 Range $0.71 - $1.54
Q3 2024
Shares 71,081 Value ($000) $56 Avg Close $0.88 Range $0.68 - $1.03
Q2 2024
Shares 71,081 Value ($000) $67 Avg Close $1.12 Range $0.84 - $1.63
Q1 2024
Shares 71,081 Value ($000) $77 Avg Close $0.69 Range $0.50 - $1.93
Q4 2023
Shares 155,481 Value ($000) $86 Avg Close $1.41 Range $0.49 - $2.89
Q3 2023
Shares 110,481 Value ($000) $233 Avg Close $2.66 Range $1.98 - $2.94
Q2 2023
Shares 110,481 Value ($000) $289 Avg Close $3.04 Range $2.26 - $3.67
Q1 2023
Shares 110,481 Value ($000) $351 Avg Close $3.14 Range $2.49 - $4.92
Q4 2022
Shares 110,481 Value ($000) $297 Avg Close $2.41 Range $1.95 - $3.14
Q3 2022
Shares 76,081 Value ($000) $221 Avg Close $2.77 Range $2.01 - $4.71